Overview
Rahul Dave is a Neurologist in Fairfax, Virginia. Dr. Dave is highly rated in 7 conditions, according to our data. His top areas of expertise are Erdheim-Chester Disease, Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), and Transverse Myelitis.
His clinical research consists of co-authoring 11 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- POS
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- HMO
- POS
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
8081 Innovation Park Dr Ste 900, Fairfax, VA 22031
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MedStar Health Headache Center At McLean
Fernando Pagan is a Neurologist in Mclean, Virginia. Dr. Pagan is highly rated in 16 conditions, according to our data. His top areas of expertise are Parkinson's Disease, Movement Disorders, Lewy Body Dementia (LBD), Benign Essential Blepharospasm, and Deep Brain Stimulation.
Pavel Klein
Pavel Klein is a Neurologist in Bethesda, Maryland. Dr. Klein is highly rated in 21 conditions, according to our data. His top areas of expertise are Seizures, Epilepsy, Generalized Tonic-Clonic Seizure, and Post-Traumatic Epilepsy.
Johns Hopkins Outpatient Center
Dr. Jaishri Blakeley is the Marjorie Bloomberg Tiven Professor of Neurofibromatosis in Neurology, Oncology, and Neurosurgery at Johns Hopkins School of Medicine, director of the Johns Hopkins Comprehensive Neurofibromatosis Center and director of the Neurofibromatosis Therapeutic Acceleration Program (NTAP). She is an active clinician-scientist specializing in the care of people with NF1, NF2, LZTR1, SMARC1 schwannomatoses, and primary brain tumors. Her research expertise in the development of clinical trials for nervous system tumors and specifically, early clinical-translational studies including tumor pharmacokinetic and pharmacodynamic investigations, imaging biomarkers for rare nervous system tumors, and incorporation of patient-focused, functional endpoints into efficacy studies. She has been the national or international leader of 7 clinical trials focused on therapies for glioblastoma, NF1 and NF2. In 2012 she cofounded the NTAP to dramatically shift the landscape of NF1 via necessary, efficient, and expert discovery, translational and clinical research. NTAP focuses on therapeutics, fosters collaboration, facilitates open and timely sharing of results, and streamlines the research process to accelerate therapies for plexiform and cutaneous neurofibromas. Through NTAP, Dr. Blakeley has supported and collaborated with more than 80 laboratories and research teams across the globe enabling meaningful therapeutic development for NF1-associated neoplasms and supporting the development of an exceptional community of clinician scientists focused on NF1 via the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research. Her research and programmatic efforts are all in the service of improving outcomes for the patients with NF1, NF2, schwannomatosis, and primary brain cancer for whom she is honored to provide care. Dr. Blakeley is highly rated in 27 conditions, according to our data. Her top areas of expertise are Neurofibromatosis, Schwannomatosis, Neurofibromatosis Type 2 (NF2), Neurofibromatosis Type 1 (NF1), and Laminectomy.
Frequently Asked Questions about Dr. Rahul Dave
How do I make an appointment with Dr. Rahul Dave?
You can book an appointment with Dr. Rahul Dave by calling their office at 571-472-4200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Rahul Dave a top-rated expert for Erdheim-Chester Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rahul Dave is classified as an Distinguished expert for Erdheim-Chester Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Rahul Dave specialize in?
While Dr. Rahul Dave is a Neurology, they have specific expertise in Erdheim-Chester Disease, Multiple Sclerosis (MS), and Relapsing Multiple Sclerosis (RMS). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.
Does Dr. Rahul Dave participate in research or clinical trials?
Yes. Dr. Rahul Dave has published 11 articles and abstracts on conditions like Erdheim-Chester Disease. You can view a list of Dr. Rahul Dave's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Rahul Dave accept my insurance?
Dr. Rahul Dave accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 571-472-4200 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Erdheim-Chester DiseaseDr. Dave isDistinguished. Learn about Erdheim-Chester Disease.
- Multiple Sclerosis (MS)Dr. Dave isDistinguished. Learn about Multiple Sclerosis (MS).
- Advanced
- EncephalitisDr. Dave isAdvanced. Learn about Encephalitis.
- Neuromyelitis OpticaDr. Dave isAdvanced. Learn about Neuromyelitis Optica.
- Optic NeuritisDr. Dave isAdvanced. Learn about Optic Neuritis.
- Relapsing Multiple Sclerosis (RMS)
- Transverse MyelitisDr. Dave isAdvanced. Learn about Transverse Myelitis.
- Experienced
- ADULT SyndromeDr. Dave isExperienced. Learn about ADULT Syndrome.
- Anti-NMDA Receptor EncephalitisDr. Dave isExperienced. Learn about Anti-NMDA Receptor Encephalitis.
- Bell's PalsyDr. Dave isExperienced. Learn about Bell's Palsy.
- Chronic Inflammatory Demyelinating Polyneuropathy
- Common Peroneal Nerve DysfunctionDr. Dave isExperienced. Learn about Common Peroneal Nerve Dysfunction.
- Facial ParalysisDr. Dave isExperienced. Learn about Facial Paralysis.